[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Walker et al., 1994 - Google Patents

Viral respiratory infections

Walker et al., 1994

Document ID
17991436545157582696
Author
Walker T
Khurana S
Tilden S
Publication year
Publication venue
Pediatric Clinics of North America

External Links

Snippet

Viral infections constitute more than 60% of acute lower respiratory illnesses. Respiratory syncytial virus (RSV) and parainfluenza viruses are the most frequent etiologic agents. After transmission by large droplet aerosol or direct contact, the viruses gain entry into host cells …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Walker et al. Viral respiratory infections
Kneyber et al. Treatment and prevention of respiratory syncytial virus infection
Mohapatra et al. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma
Barry et al. Ribavirin aerosol for acute bronchiolitis.
Englund et al. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients
Bonville et al. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents
Rimensberger et al. Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants
Jakeman et al. Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets
CN102716105B (en) Dry powder inhalant of interferon Alpha
Nicolai et al. Acute viral bronchiolitis in infancy: epidemiology and management
WO2015027848A1 (en) Method of administering formulation comprising peramivir and/or derivative thereof
CN105920586A (en) Interferon aerosol propellant
Kimpen Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
van Woensel et al. Therapy for respiratory tract infections caused by respiratory syncytial virus
Wiselka et al. Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease.
Garzon et al. Management of respiratory syncytial virus with lower respiratory tract infection in infants and children
Rose et al. Viral infection of the lower respiratory tract
US7132453B2 (en) Method of using prostacyclin to treat respiratory syncytial virus infections
EP4232073B1 (en) New dosage regimen for inhaled vasoactive intestinal polypeptide
Ali et al. Comparison of Hypertonic Saline vs Salbutamol in Normal Saline Nebulization in Children with Bronchiolitis
Chávez-Bueno et al. Respiratory syncytial virus: old challenges and new approaches
JP2023520929A (en) Methods for treatment of coronavirus infection
Hickey et al. Albuterol delivered via metered-dose inhaler with spacer for outpatient treatment of young children with wheezing
US20100267616A1 (en) Acute respiratory syndromes
US20230030607A1 (en) Novel oxygen pulse therapy method for treating COVID19 and viral, bacterial, fungal or parasitic respiratory and other diseases